DHX58 (DExH-box helicase 58)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
79132 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
DExH-box helicase 58 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
DHX58 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
D11LGP2, D11lgp2e, LGP2, RLR-3 |
Chromosome
Chromosome number
|
17 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
17q21.2 |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | ||||||||||||||||||||||||||
UniProt ID | Q96C10 | |||||||||||||||||||||||||
Protein name | ATP-dependent RNA helicase DHX58 (EC 3.6.4.13) (ATP-dependent helicase LGP2) (Protein D11Lgp2 homolog) (RIG-I-like receptor 3) (RLR-3) (RIG-I-like receptor LGP2) (RLR) | |||||||||||||||||||||||||
Protein function | Acts as a regulator of RIGI and IFIH1/MDA5 mediated antiviral signaling. Cannot initiate antiviral signaling as it lacks the CARD domain required for activating MAVS/IPS1-dependent signaling events. Can have both negative and positive regulatory | |||||||||||||||||||||||||
PDB | 2RQA , 2W4R , 3EQT | |||||||||||||||||||||||||
Family and domains |
Pfam
|
|||||||||||||||||||||||||
Tissue specificity | TISSUE SPECIFICITY: Expressed in testis, nerve and spleen. Also expressed in the brain. {ECO:0000269|PubMed:31256877}. | |||||||||||||||||||||||||
Sequence | ||||||||||||||||||||||||||
Sequence length | 678 | |||||||||||||||||||||||||
Interactions | View interactions |
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|||||||||
|
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|